title: Acne: What's New.
abstract: Acne vulgaris is one of the most prevalent skin conditions. Antibiotics, when considered, are most effective in combination with other therapies, and limited evidence suggests that submicrobial doses of antibiotics may improve acne without increasing the risk for antibiotic resistance. A small but significant risk for inflammatory bowel disease has also been identified in children treated with multiple courses of antibiotics. New topical agents are expanding therapeutic options for acne. Semin Cutan Med Surg 35(supp6):S114-S116.
authors.affiliation: Director of Dermatology Research Henry Ford Health System Detroit, Michigan.
authors.forename: Linda F
authors.initials: LF
authors.lastname: Stein Gold
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000279:Administration, Cutaneous; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000139:chemically induced; D012629:Sebum / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents
keywords: Acne vulgaris; antibiotics; inflammatory bowel disease; topical therapy